By applying logistic regression to assess test performance of combined NT-proBNP and IL-1 RL1 analysis in high-risk CHD vs controls, the combined screening test showed 93.0% accuracy (sensitivity, 93.6%; specificity, 91.8%). This evidence concerns the gene NPPB and coronary artery disorder.